LINZIE HEBERT: Open Payments
NPI 1467635383 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 42 payments from 12 companies in 2025. Trend: 2023 $1,324 · 2024 $934 · 2025 $795
Food & beverage: $715Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $220 |
| Janssen Biotech, Inc. | 5 | $156 |
| GENZYME CORPORATION | 8 | $149 |
| Lilly USA, LLC | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Organon LLC | 2 | $28 |
| PFIZER INC. | 1 | $26 |
| Arcutis Biotherapeutics, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $20 |
| Incyte Corporation | 1 | $20 |
Products named: RINVOQ, TREMFYA, DUPIXENT, TALTZ, SKYRIZI, COSENTYX, VTAMA, CIBINQO.
Industry payments across LA — which companies pay providers there.
